Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.
3.

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.

Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.

Am J Hematol. 2005 Jan;78(1):49-54.

4.

Metastatic choriocarcinoma in a middle-aged man presenting as a right thigh mass with venous thrombosis: a case report.

Blokh I, Oiseth SJ, Fuks J, Jain D, Eapen S, Koulova L, Alexandrescu D, Li YY, Dutcher J, Wiernik PH.

Med Oncol. 2003;20(2):189-94.

PMID:
12835524
5.

Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L.

Springer Semin Immunopathol. 1998;20(3-4):455-91. Review. No abstract available.

PMID:
9870257
6.

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L.

Immunol Rev. 1997 Jun;157:195-216. Review.

PMID:
9255631
7.

The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.

Young JW, Koulova L, Soergel SA, Clark EA, Steinman RM, Dupont B.

J Clin Invest. 1992 Jul;90(1):229-37. Erratum in: J Clin Invest 1993 Apr;91(4):1853.

8.

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.

Koulova L, Clark EA, Shu G, Dupont B.

J Exp Med. 1991 Mar 1;173(3):759-62.

9.

Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.

Koulova L, Yang SY, Dupont B.

J Immunol. 1990 Oct 1;145(7):2035-43.

PMID:
1697875

Supplemental Content

Loading ...
Support Center